Stocksigma LogoStocksigma Logo

USFDA Concludes Surveillance Inspection at Shilpa Medicare's Unit VII Analytical Facility

The USFDA concluded a surveillance inspection at Shilpa Medicare's Unit VII Analytical Services Division in Hyderabad on 18th Sep'26 with one procedural

USFDA Concludes Surveillance Inspection at Shilpa Medicare's Unit VII Analytical Facility

Shilpa Medicare Ltd 路 Others (Uncategorized) 路 19 Sept 2026, 12:24 am

USFDA Concludes Surveillance Inspection at Shilpa Medicare's Unit VII Analytical Facility The USFDA concluded a surveillance inspection at Shilpa Medicare's Unit VII Analytical Services Division in Hyderabad on 18th Sep'26 with one procedural observation. The observation is neither a repeat issue nor related to data integrity. The company plans to submit a response with corrective and preventive actions within the stipulated timeline and expects no material impact on current business operations or existing supplies from the facility.

Original exchange filing (PDF)

More announcements from Shilpa Medicare Ltd

All Shilpa Medicare Ltd announcements